Scientific article
Open access

Development of skin diseases following systemic exposure: example of dioxins

Published inFrontiers in toxicology, vol. 5, 1243192
Publication date2023-08-28
First online date2023-08-28

Most skin manifestations of exposure to toxic compounds are a consequence of a direct contact with the toxicants. However, some toxicants may reach the skin following systemic exposure, and promote skin diseases. Good examples of such chemicals are dioxin-like compounds. This family of lipophilic molecules comprises polychlorinated (dibenzodioxins, dibenzofurans and biphenyls). The most potent member of this family is 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Following oral ingestion of as little as a few mg TCDD, skin lesions appear in a couple of weeks, starting from the face and diffuse then on the trunk and limbs. This syndrome was historically called “chloracne” and the skin lesions have now been shown to be skin hamartoma induced by TCDD. Sebaceous glands release their lipid content on the surface of the skin by a holocrine secretion, and so any lost sebocyte should be transmitted to progenitor cells to differentiate and migrate to the sebaceous gland to replace the lost sebocyte. TCDD acts by inducing a switch in this signal and skin hamartoma develop in place of new sebocytes.

  • AhR
  • Biomarkers
  • Dioxin
  • Ingestion
  • Skin
  • Toxicology
Citation (ISO format)
SORG, Olivier, SAURAT, Jean-Hilaire. Development of skin diseases following systemic exposure: example of dioxins. In: Frontiers in toxicology, 2023, vol. 5, p. 1243192. doi: 10.3389/ftox.2023.1243192
Main files (1)
Article (Published version) - After correction
Updates (1)
ISSN of the journal2673-3080

Technical informations

Creation09.10.2023 14:46:49
First validation22.02.2024 17:23:56
Update time22.02.2024 17:23:56
Status update22.02.2024 17:23:56
Last indexation22.02.2024 17:24:16
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack